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INTRODUCTION
According to the annual Report of the Korean Central Can-
cer Registry (1), the total number of cancer patients registered
in Korea is approximately 90,000 (2). Pain is the most com-
mon and offensive symptom in cancer patients, and pain with-
out the hope of relief severely damages their quality of life.
A multi-center study with general or university hospitals
showed that 52.1% of cancer patients suffer from pain, and
62.6% among them are not satisfied with the current pain
control (2). This might be attributed to the patients them-
selves, the social system, and cultural perspectives but some
responsibility can be leveled at the medical care team that
does not evaluate the cancer pain properly. Pain is regarded
to be the 5th vital sign, and establishing a treatment plan
according to the pain intensity is essential (2).
Pain is an unpleasant experience related to the substantial
or potential tissue damage (3). Cancer pain was explained by
the concept of ‘‘total pain’’ (somato-pshychic experience) by
Saunders (4) and can be affected by physical factors as well as
psychosocial and spiritual factors. Therefore, understanding
the mental, social, spiritual and physical problem is funda-
mental, and it is the most important first step in cancer pain
management. Because pain is a subjective symptom, an appro-
priate and objective cancer pain assessment tool, with a proven
reliability and validity, is needed and the descriptions of pain
by the patients need to be trusted.
The initial assessment of cancer patients must be focused
on elucidating the cause of the pain and establishing a man-
agement plan. For this purpose, the control of cancer pain
should be done with a continuous assessment of the pain with
consideration of the psychosocial aspects as well as the quality,
initiation, changes over time, history of management, and
desire to control the pain. 
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Reliability and Validity of the Korean Cancer Pain Assessment Tool
(KCPAT)
The Korean Cancer Pain Assessment Tool (KCPAT), which was developed in 2003,
consists of questions concerning the location of pain, the nature of pain, the present
pain intensity, the symptoms associated with the pain, and psychosocial/spiritual pain
assessments. This study was carried out to evaluate the reliability and validity of the
KCPAT. A stratified, proportional-quota, clustered, systematic sampling procedure
was used. The study population (903 cancer patients) was 1% of the target popu-
lation (90,252 cancer patients). A total of 314 (34.8%) questionnaires were collected.
The results showed that the average pain score (5 point on Likert scale) according
to the cancer type and the at-present average pain score (VAS, 0-10) were corre-
lated (r=0.56, p<0.0001), and showed moderate agreement (kappa=0.364). The
mean satisfaction score was 3.8 (1-5).  The average time to complete the question-
naire was 8.9 min. In conclusion, the KCPAT is a reliable and valid instrument for
assessing cancer pain in Koreans. 
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There are several pain assessment tools such as the Visual
Analogue Scale (5), the Verbal Numeric Rating Scale (5), the
Verbal Rating Scale (6), the Faces Pain Scale (7), the Brief Pain
Inventory (8), the Memorial Pain Assessment Card (9) and
The McGill Pain Questionnaire (10). However, these assess-
ment tools cannot be applied to Koreans with any hope of
meaningful analysis because, besides the issues of copyright,
reliability and validity, they were merely translated after being
developed in a completely different cultural background.
Therefore, the ‘practical committee for cancer pain assessment
tool’ was organized in August 2002. By May 2003 ‘Korean
Cancer Pain Assessment Tool’ (KCPAT) was developed after
20 meetings at consultant conferences (11). The KCPAT con-
sists of the following 1) the location of the pain using a body
chart, 2) the nature of the pain and the pain intensity using
the pain expression descriptions, 3) the current pain intensi-
ty using the Visual Analogue Scale (VAS), 4) the accompany-
ing symptoms affecting the pain, and 5) psychosocial items
affecting the pain.
The validity and reliability of the ‘KCPAT’ was assessed. 
MATERIALS AND METHODS
Subjects
According to the 2001 Korean Cancer Central Registry
Report, there were Korean 91,944 cancer patients (2001).
There were 51,753 (56.3%) males and 40,191 (43.7%) fe-
males. 90,252 patients were chosen for the population of this
study after excluding those patients with an unknown address,
age <18 yr (1,673 persons) and those who were not contac-
table. Among the study population, 903 patients (1%) were
selected as the study sample. An investigation of whole study
subjects was performed in a tertiary hospital (mainly universi-
ty hospitals) from May to August 2003. 
Sampling method
A stratified proportional-quota and clustered systematic
sampling method were used to sample the study population.
After stratifying the entire country to various administrative
sectors, a sample number proportional to the target popula-
tion was allocated to a stratified area. An oncologist was select-
ed from each university hospital in each group, which was
considered to be a cluster. The oncologists selected were re-
quested to interview the cancer patients, regardless of gender,
age, and type or stage of cancer using the systemic sampling
method as follows (Table 1).
The systemic sampling method given to the oncologists
was as follows: 
‘‘Please, divide the one week’s number of patients including
the hospitalized and out-patients (regardless of gender, age,
and type or stage of cancer) by the number of interviewees
allocated to you.
For example, if the total number of patients seen by you
in a week is 50 and the number of interviewees allocated to
you was 12, the selected number would be 4 (50/12=4.17
→ In the case of 4.17, 4 is chosen). Then, apportion a tempo-
rary serial number to each patient. After choosing a number
from 1-4, interview the patient whose number is the sum of
4 and the chosen number. For example, if number 1 is chosen,
the patients numbered 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41,
and 45 should be interviewed. If number 3 is chosen, patients
whose numbers are 3, 7, 11, 15, 19, 23, 27, 31, 35, 39, 43,
and 47 should be interviewed etc. This method established
the representation of the sample regardless of gender, age and
the type or stage of cancer. In the case of patients age below







RespondentsAbove 18 yr (%)
Seoul 21,644 21,277 (23.6) 21 213 10 117 54.9%
Busan 7,574 7,457 (8.3) 3 75 25 23 30.7%
Daegu 5,076 4,990 (5.5) 5 50 10 10 20.0%
Incheon 4,230 4,139 (4.6) 2 41 21 20 48.8%
Gwangju 2,149 2,093 (2.3) 1 21 21 14 66.7%
Daejeon 2,348 2,301 (2.5) 4 23 6 6 26.1%
Ulsan 1,299 1,270 (1.4) 1 13 13 12 92.3%
Gyeonggi 16,880 16,537 (18.3) 9 165 18 46 27.9%
Gangwon 3,356 3,312 (3.7) 3 33 11 18 54.5%
Chungbuk 2,672 2,628 (2.9) 1 26 26 0 0%
Chungnam 3,883 3,823 (4.2) 2 38 19 18 47.4%
Jeonbuk 3,620 3,553 (3.9) 2 36 18 16 44.4%
Jeonnam 4,058 3,986 (4.4) 2 40 20 0 0%
Gyeongbuk 6,541 6,453 (7.1) 2 65 33 14 21.5%
Gyeongnam 5,749 5,643 (6.3) 2 56 28 0 0%
Jheju 810 790 (0.9) 1 8 8 0 0%
Total 91,889 90,252 (100) 61 903 314 34.8%
Table 1. The dstribution of the target population and the number of survey samples with the response rates
Rate of respon-
dents (%)
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18 yr, no current pain at interview, and where communication
was difficult, the next patient in the series should be inter-
viewed.’’ 
RESULTS
Demographic characteristic of subjects
The response rate was 34.8% with 314 people from 903
subjects. 170 persons (54.1%) were male and 144 (45.9%)
were female (the male to female ratio of the total cancer pa-
tients was 1.29). The mean age was 56.34±11.78 yr, 57.0±
11.3 yr in males, and 55.6±12.4 yr in females. The majority
of patients had a metastasis (217 persons, 71.6%) and was
hospitalized (255 persons, 81.5%).
Reliability of KCPAT
The reliability of the questionnaire could not be measured
by Cronbach-alpha because the items were not structured sep-
arately. However, the inner consistency was checked by the
correlation of the ‘average pain score along the pain nature
(somatic pain, visceral pain, neuropathic pain) on a 5-point
on Likert scale’ and the ‘present pain intensity on the VAS’.
The mean pain score was 3.01±1.10 in the patients com-
plaining of pain. The mean score was 3.13±1.00 (214 per-
sons) in those with somatic pain, 2.96±1.11 (197 persons)
in those with visceral pain, and 2.83±1.03 (106 persons) in
those with neuropathic pain.
The present pain intensity evaluated on the VAS was 4.51
±2.49 and it showed an internal consistency (r=0.560, p<
0.0001). When the pain score along with the nature of the
pain was compared with the pain score on the VAS, the agree-
ment of the mean score was 0.364±0.0344 in Kappa (95%
CI=0.302-0.437) (Table 2).
Validity of KCPAT
The oncologist, family doctor, pain vocabulary specialist,
hospice nurse, social worker, Korean language scholar, English
language scholar, medical statistician and a social psycholo-
gist provided the specialist validity. The questionnaire was
developed after many conferences examining several foreign
questionnaires with proven reliability and validity.
The investigators were requested to write down any expres-
sion of pain besides the 5 pain descriptions used in previous
research. The descriptions, reported by more than 10% of the
respondents, were examined for the content validity under a
90% confidence level. In the case of psychosocial and accom-
panying symptoms, the content validity was examined by
checking for any items beyond 10% in the other opinions be-
sides the selected items. The practical committee also reor-
dered the questions according to frequency of pain expression.
A particular pain expression with a frequency exceeding 20%
was added to each section. 
The frequency of the 5 selected expressions of somatic pain
was as follows: ‘throbbing’ (109 persons, 36.0%), ‘tight’ (79
persons, 26.1%), ‘splitting’ (50 persons, 16.5%), ‘tearing’ (37
persons, 12.2%), and ‘stabbing’ (28 persons, 9.2%).
The prevalence of somatic pain was 68.2% (214 persons/
314 persons). The number of pain descriptions selected was 1
in 135 patients (43.0%), 2 in 53 patients (16.6%), 3 in 20
patients (6.4%), 4 in 2 patients (0.6%), and 5 in 5 patients
(1.6%) (Table 3). The number of other descriptions about the
somatic pain was 15. The frequency of the other descriptions
is as follows: ‘heavy’ (6 persons, 40%), ‘dull’ (3 persons, 20%),
‘crushing’ (2 persons, 13.3%), ‘tightness’ (1 person), ‘ache’ (1
person), ‘exploding’ (1 person), and ‘taut’ (1 person). ‘Heavi-
ness’, which was the most frequent answer, was added to the
questionnaire. 
The frequency of the 5 selected expressions of visceral pain
is as follows: ‘ache’ (88 patients, 34.8%), ‘throbbing’ (52 pa-
tients, 20.6%), ‘sore’ (42 patients, 16.6%), ‘wrenching’ (38
patients, 15.0%), and ‘cramping’ (33 patients, 13.0%). The
prevalence of visceral pain was 62.7% (197/314 persons). The
number of selected pain descriptions was 1 in 138 persons
(44.0%), 2 in 43 persons (13.7%), 3 in 9 persons (2.9%), 4
in 1 person (0.3%), and 5 in 6 persons (1.9%) (Table 3). The
number of other visceral pain descriptions was 21. The fre-
quency of the other descriptions is as follows: ‘heavy’ (5 per-
sons, 20%), ‘dull’ (3 persons), ‘tightness’ (3 persons), ‘pulling’
(0, 1) 15 3 2 0 0 20
(1, 2) 19 29 7 3 0 58
(2, 3) 16 31 37 25 3 112
(3, 4) 8 12 25 35 14 94
(4, 5) 4 2 5 11 8 30
Total 62 77 76 74 25 314
Table 2. Correlation between the average pain score along the





(0, 2) (2, 4) (4, 6) (6, 8) (8, 10) Total 0 100 (31.8) 117 (37.2) 207 (65.9)
1 135 (43.0) 138 (44.0) 68 (21.7)
2 52 (16.6) 43 (13.7) 21 (6.7)
3 20 (6.4) 9 (2.9) 9 (2.9)
4 2 (0.6) 1 (0.3) 3 (0.9)
5 5 (1.6) 6 (1.9) 6 (1.9)





Somatic pain Visceral pain Neuropathic pain
Prevalence
by type of pain
68.2% 62.7% 34.1%
880 J. A. Kim, Y.S. Choi, J. Lee, et al.
(3 persons), ‘stinging’ (2 persons), ‘pricking’ (1 person), ‘break-
ing’ (1 person), ‘cutting’ (1 person), ‘smarting’ (1 person), and
‘pounding’ (1 person). ‘Heaviness’, which was the most fre-
quent answer, was added to the questionnaire. 
The frequency of the 5 selected descriptions of neuropahic
pain is as follows: ‘numbness’ (50 persons, 30.1%), ‘tingling’
(39 persons, 23.5%), ‘burning sensation’ (32 persons, 19.3%),
‘shooting’ (24 persons, 14.4%), and ‘allodynia’ (21 persons,
12.7%). The prevalence of neuropathic pain was 34.1% (107/
314 persons). The number of pain descriptions selected was
1 in 68 persons (21.7%), 2 in 21 persons (6.7%), 3 in 9 per-
sons (2.9%), 4 in 3 persons (0.9%), and 5 in 6 persons (1.9%)
(Table 3). Additional descriptions were not chosen because
there was no answer occurring more frequently than 20%.
The frequency of the 10 items of accompanying symptoms
besides pain using the ‘Memorial Symptom Assessment Scale’
is as follows. ‘anorexia’ (194 persons, 17.6%), ‘inertia’ (177
persons, 16.0%), ‘sleep disturbance’ (128 persons, 11.6%),
‘thirsty’ (106 persons, 9.6%), ‘weight loss’ (106 persons, 9.6
%), ‘constipation’ (10 persons, 9.2%), ‘decreased concentra-
tion’ (95 persons, 8.6%), ‘dizziness’(92 persons, 8.3%), ‘sleepy’
(71 persons, 6.4%), and ‘itching sensation’ (34 persons, 3.1%).
The number of other descriptions was 25, which were as fol-
lows: ‘nausea’ (5 persons, 25%), ‘cough’ (3 persons, 12%),
breathing difficulty (2 persons), diarrhea (2 persons), dyspnea
(2 persons), difficulty in micturation (2 persons). ‘Nausea’ and
‘cough’ were added to the questionnaire because their frequen-
cy was >10%. ‘Thirsty’ was changed to ‘dry mouth’.
The frequency of the 8 psychosocial items is as follows: ‘su-
pport from family’ (171 persons, 26.1%), ‘compliance for pain
killer’ (245 persons, 23.7%), ‘response type to stress’ (156 per-
sons, 15.1%), ‘current emotional state such as anxiety or de-
pression’ (142 persons, 13.7%), ‘spiritual suffering on current
state of patient oneself’ (91 persons, 8.8%), ‘ability or inability
of self control’ (86 persons, 8.3%), ‘drug dependency or addic-
tion’ (38 persons, 3.7%), and ‘past history of psychiatric ill-
ness’ (6 persons, 0.6%). The order of the psychosocial items
was adjusted according to the answer frequency. 
Satisfaction on KCPAT 
Twenty-six oncologists participated in the inquiry, 12 (46.2
%) from Seoul, 3 (11.5%) from Kyungi province, 2 (7.7%)
from Gangwon province, and one person each from Busan,
Daegu, Incheon, Gwangju, Daejeon, Ulsan, Chungnam,
Jeonbuk, and Gyeungbuk. Twenty of the oncologists (76.9%)
were male and 6 (23.1%) were female. The mean age of the
respondents was 39.8±6.34 yr. The average completion time
of the questionnaire was 8.9±5.29 min in 18 respondents
and the satisfaction level was 3.8±0.79 (5-point Likert scale).
The correlation of the average completion time and the sat-
isfaction level is shown in Table 4. 
DISCUSSION
KCPAT can be used for initial cancer pain assessment by
interviewer. It consists of the following: 1) the location of
the pain using a body chart, 2) the type of the pain and the
pain intensity using the pain expression descriptions, 3) the
present pain intensity using the Visual Analogue Scale, 4) the
accompanying symptoms affecting the pain, and 5) psychoso-
cial items affecting the pain. The patents can respond with
the plural form on each item with the exception of item 3.
The KCPAT also can be used in a periodic reevaluation after
medical intervention. The intensity of the pain can be checked
with the ‘average pain score along the pain nature’ and ‘present
pain score’.
The descriptions used in the KCPAT were corrected based
on the reliability and validity examined, and they were also
reordered according to the frequency of the answers. After
modifying the questions, an evaluator’s manual was produced.
The completion time of the KCPAT was less than ten minutes.
Although pain is common problem in cancer patients, the
management of pain is still inappropriate in Korea (12). This
inappropriate management of pain is mainly due to the lack
of pain assessment tool as well as lack of education for assess-
ing the pain (13-15). 
The KCPAT was developed to evaluate the cancer pain in
Korean adults and it is a tool consistent with the total pain
concept. Lee et al. reported that the average pain score was
3.80 (0-10 point scale) and the satisfaction score on cancer
pain management was 4.19 (1-6 point scale) (11).
The background of developing KCPAT is increasing na-
tional interest of cancer pain. The interest of cancer pain make
it possible to develop the guideline for cancer management
by the Korean Society of Hospice and Palliative Care (2).
Oncologists who evaluated cancer pain using the KCPAT
reported the possibility of an overestimation in the case of
incidental pain, the need for diversifying the pain descriptions,
supplementing the content for the continuous evaluation of
pain, and analyzing the level of pain control by observing the
response after the pain control measure.
There were some limitations in this study. The first is that
discriminating the pain nature was difficult due to the dif-
ference in knowledge and expression between doctors and
patients. The second is the difficulty in delivering a psycho-
≤5 0 (0.0) 1 (12.5) 0 (0.0) 6 (75.0) 1 (12.5) 8 (100)
6-10 0 (0.0) 0 (0.0) 1 (16.7) 4 (66.7) 1 (16.7) 6 (100)
11-20 0 (0.0) 1 (25.0) 0 (0.0) 3 (75.0) 0 (0.0) 4 (100)
Table 4. Correlation between the time required to fill out the





1 2 3 4 5 Total
(useless) (very useful)
Total 0 2 1 11 2 18
logical concept even with the provision of an evaluator’s man-
ual. The third is that pain can be under or overestimated be-
cause the pain duration was not written in the questionnaire,
the ‘Average pain score along with the nature’ might reflect
only the current pain intensity. 
Although there are some limitations, the importance of
this study is that KCPAT is the first qualitative and quanti-
tative pain assessment tool that was developed in Korean lan-
guage. Therefore, the effect of KCPAT is extensive in the part
of education for physician without mentioning the assessment
of cancer pain. In addition, even though the KCPAT was de-
veloped for evaluating cancer pain, it can also be used as a
basis for future treatments by reducing the administration
of unnecessary medications and operations. Moreover, it will
contribute to an evaluation of the quality of life of cancer pa-
tients because it can assess the efficacy of the treatments. How-
ever, a simpler tool that is more appropriate for a clinical set-
ting and one that patients can complete by themselves needs
to be developed. With this continuous feedback, the KCPAT
can be revised and improved.
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